Antimicrobial Synergy Testing: Comparing the Tobramycin and Ceftazidime Gradient Diffusion Methodology Used in Assessing Synergy in Cystic Fibrosis-Derived Multidrug-Resistant <i>Pseudomonas aeruginosa</i>
The need for synergy testing is driven by the necessity to extend the antimicrobial spectrum, reducing drug dosage/toxicity and the development of resistance. Despite the abundance of synergy testing methods, there is the absence of a gold standard and a lack of synergy correlation among methods. Th...
Main Authors: | Ijeoma N. Okoliegbe, Karolin Hijazi, Kim Cooper, Corinne Ironside, Ian M. Gould |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/10/8/967 |
Similar Items
-
A Pilot Study of the Synergy between Two Antimicrobial Peptides and Two Common Antibiotics
by: Franziska Kampshoff, et al.
Published: (2019-05-01) -
Reduced Ceftazidime-Avibactam Susceptibility in KPC-Producing Klebsiella pneumoniae From Patients Without Ceftazidime-Avibactam Use History – A Multicenter Study in China
by: Xiaoyan Cui, et al.
Published: (2020-06-01) -
Synergy Pattern of Short Cationic Antimicrobial Peptides Against Multidrug-Resistant Pseudomonas aeruginosa
by: Serge Ruden, et al.
Published: (2019-11-01) -
Synergy between Florfenicol and Aminoglycosides against Multidrug-Resistant <i>Escherichia coli</i> Isolates from Livestock
by: Shukho Kim, et al.
Published: (2020-04-01) -
Modified Double Disc Synergy Test to Detect ESBL Production in Urinary Isolates of Escherichia coli and Klebsiella pneumoniae
by: Jaspal Kaur, et al.
Published: (2013-02-01)